The authors confirmed that low levels of Aβ42 in the CSF were an α-syn-independent predictive factor for cognitive decline in PD, while no prognostic value was determined for any of the other assessed biomarkers, (i.e., total/phospho Tau and total/oligomers α-syn) [115]. Here, MAPT is linked to Parkinson disease.